HOME- 자료실
- 최신 논문
SITE MAP
-
학회소개
-
학회소식
-
학술행사
-
분과전문의
-
자료실
-
학회지(JGO)
-
관련 사이트
총 게시글 : 196
-
Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer. 2024-09-24 VIEW : 9
-
Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer. 2024-09-24 VIEW : 1
-
Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort 2024-09-24 VIEW : 44
-
Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning 2024-09-24 VIEW : 10
-
Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study 2024-09-24 VIEW : 0
-
GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 tria 2024-09-24 VIEW : 10
-
Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan 2024-09-24 VIEW : 9
-
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study 2024-09-24 VIEW : 13
-
Choosing the right adjuvant therapy for stage III–IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy 2024-09-24 VIEW : 1
-
Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis 2024-09-24 VIEW : 3
-
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 2024-06-26 VIEW : 36
-
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations 2024-06-26 VIEW : 13
-
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer 2024-06-26 VIEW : 17
-
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial 2024-06-26 VIEW : 5
-
Vulvar Carcinoma: Standard of Care and Perspectives 2024-06-26 VIEW : 10